These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 4615717)
41. CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients. Villeneuve C; Ananth JV; Ban TA; Lehmann HE Curr Ther Res Clin Exp; 1970 Apr; 12(4):223-9. PubMed ID: 4985943 [No Abstract] [Full Text] [Related]
42. [Enuresis in therapy with psychotropic drugs]. Zahno A; Ramseier E; Hruz P Praxis (Bern 1994); 2007 Sep; 96(36):1357-8. PubMed ID: 17894120 [No Abstract] [Full Text] [Related]
43. A pilot study on the use of AL-1021 in the treatment of acute schizophrenics. Gendron JL; Schiele BC Curr Ther Res Clin Exp; 1971 Mar; 13(3):169-73. PubMed ID: 4998288 [No Abstract] [Full Text] [Related]
44. [Structural chromosome aberrations produced in lymphocytes of healthy subjects by growth in varying culture conditions]. Meist H Acta Genet Med Gemellol (Roma); 1971 Apr; 20(2):174-88. PubMed ID: 5093125 [No Abstract] [Full Text] [Related]
46. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses]. Vinci M Osp Psichiatr; 1971; 39(2):399-407. PubMed ID: 4948707 [No Abstract] [Full Text] [Related]
47. A pilot study of pimozide in chronic schizophrenic patients. Sugerman AA Curr Ther Res Clin Exp; 1971 Nov; 13(11):706-13. PubMed ID: 5000718 [No Abstract] [Full Text] [Related]
48. Cytogenetic effects of tranquilizing drugs in vivo and in vitro. Cohen MM; Hirschhorn K; Frosch WA JAMA; 1969 Mar; 207(13):2425-6. PubMed ID: 5818444 [No Abstract] [Full Text] [Related]
50. Pimozide treatment of chronic schizophrenics as compared with haloperidol and penfluridol maintenance treatment. A multidisciplinary approach. Baro F; Van Lommel R; Dom R; De Mesmaecker L Acta Psychiatr Belg; 1972 Mar; 72(2):199-214. PubMed ID: 5056015 [No Abstract] [Full Text] [Related]
51. Diphenoxylate in diarrhoea and vomiting. Practitioner; 1972 Jul; 209(249):99-102. PubMed ID: 4261229 [No Abstract] [Full Text] [Related]
52. A pilot investigation in neuroleptic therapy. Mattke DJ Dis Nerv Syst; 1968 Aug; 29(8):515-24. PubMed ID: 4877897 [No Abstract] [Full Text] [Related]
53. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702 [TBL] [Abstract][Full Text] [Related]
54. Experience with a new butyrophenone derivative (Buronil). Vangtorp A; Simmelsgaard H; Mellegaard M Acta Psychiatr Scand Suppl; 1968; 203():235-8. PubMed ID: 4881877 [No Abstract] [Full Text] [Related]
55. The pharmacology of dehydrobenzperidol, a new potent and short acting neuroleptic agent chemically related to Haloperidol. JANSSEN PA; NIEMEGEERS CJ; SCHELLEKENS KH; VERBRUGGEN FJ; VAN NUETEN JM Arzneimittelforschung; 1963 Mar; 13():205-11. PubMed ID: 13957425 [No Abstract] [Full Text] [Related]
56. Extrapyramidal side effects and tolerability of risperidone: a review. Owens DG J Clin Psychiatry; 1994 May; 55 Suppl():29-35. PubMed ID: 7520906 [TBL] [Abstract][Full Text] [Related]
57. The prophylactic effect of haloperidol plus dexamethasone on postoperative nausea and vomiting in patients undergoing laparoscopically assisted vaginal hysterectomy. Chu CC; Shieh JP; Tzeng JI; Chen JY; Lee Y; Ho ST; Wang JJ Anesth Analg; 2008 May; 106(5):1402-6, table of contents. PubMed ID: 18420851 [TBL] [Abstract][Full Text] [Related]
58. [Hypothermia during use of pipamperone]. Eikenboom HC; Janssens AR; Rosekrans PC; Molendijk W Ned Tijdschr Geneeskd; 1997 Feb; 141(6):301-3. PubMed ID: 9148168 [TBL] [Abstract][Full Text] [Related]
59. [Psychodynamic and sociodynamic changes produced by methylperidol]. Leal R Actas Luso Esp Neurol Psiquiatr; 1969 Oct; 28(4):299-305. PubMed ID: 5394271 [No Abstract] [Full Text] [Related]
60. [Correction by dihydroergotamine of arterial pressure disorders induced by psychiatric chemotherapy]. Kammerer T; Tyano S Ann Med Psychol (Paris); 1968 Feb; 1(2):269-75. PubMed ID: 5651950 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]